Wealth Watch Advisors’s Amgen AMGN Stock Holding History

Wealth Watch Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-24	Closed	-$7.86K	–	161
2025 Q4	$7.86K	Hold	24	–	–	﹤0.01%	459
2025 Q3	$6.77K	Buy	+24	New	+$6.96K	﹤0.01%	460

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wealth Watch Advisors's AMGN Position: Q1 2026 in Review

Wealth Watch Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 24 shares — an estimated $7.86K sold.

Wealth Watch Advisors first reported a position in AMGN in Q3 2025 and held it in 2 quarters. The position peaked at $7.86K in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Wealth Watch Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Wealth Watch Advisors sold 24 Amgen shares in Q1 2026, an estimated $7.86K.
Wealth Watch Advisors first reported a position in Amgen in Q3 2025 and held it in 2 quarters.
Wealth Watch Advisors's Amgen position peaked at $7.86K in Q4 2025.
3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wealth Watch Advisors's 13F filing for Q1 2026, filed 15 May 2026.